Ocular drug delivery is one of the most challenging endeavors among the various available
drug delivery systems. Despite having suitable drugs for the treatment of ophthalmic …

The most common cause of untreatable vision loss is dysfunction of the retina. Conditions,
such as age-related macular degeneration, diabetic retinopathy and glaucoma remain …

Photoreceptor apoptosis is recognized as one key pathogenesis of retinal degeneration, the
counteraction of which represents a promising approach to safeguard visual function …

Enabling near-infrared light sensitivity in a blind human retina may supplement or restore
visual function in patients with regional retinal degeneration. We induced near-infrared light …

Many research projects are underway to improve the diagnosis and therapy in
ophthalmology. Indeed, visual acuity deficits affect 285 million people worldwide and …

The use of multipotent mesenchymal stem cells (MSCs) has been reported as promising for
the treatment of numerous degenerative disorders including the eye. In retinal degenerative …

Purpose The aim of this study is to determine if umbilical cord Wharton's jelly derived
mesenchymal stem cells implanted in sub-tenon space have beneficial effects on visual …

Purpose The aim of the study was to investigate annual structural and functional results, and
their correlation with inheritance pattern of retinitis pigmentosa (RP) patients who were …

Mesenchymal stem cell (MSC) transplantation is emerging as an ideal tool to restore the
wounded central nervous system (CNS). MSCs isolated from extra-embryonic tissues have …

Background Currently, there is no treatment for retinal degenerative diseases (RDD) such as
retinitis pigmentosa (RP). Stem cell-based therapies could provide promising opportunities …